Isoflurane provides neuroprotection in neonatal hypoxic ischemic brain injury

Journal of Investigative Medicine

Volumn 61, Issue 7, 2013, Pages 1078-1083

  Burchell, Sherrefa R ^a   Dixon, Brandon J ^a   Tang, Jiping ^a   Zhang, John H ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Isoflurane; Isoflurane mechanism; Long term neuroprotection; Neonatal hypoxia ischemia; Postconditioning; Preconditioning

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; ALDEHYDE DEHYDROGENASE ISOENZYME 2; CALCIUM ION; CASPASE 3; CREATINE KINASE MB; FOCAL ADHESION KINASE 2; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; ISOFLURANE; LACTATE DEHYDROGENASE; LYSOPHOSPHOLIPID; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 6; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C; POTASSIUM CHANNEL; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN P90; REACTIVE OXYGEN METABOLITE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE 1; VOLATILE AGENT;

ACUTE LUNG INJURY; ANIMAL MODEL; APOPTOSIS; BRAIN HEMORRHAGE; CONFERENCE PAPER; CYTOKINE PRODUCTION; HEART INJURY; HEART MUSCLE CELL; HEMORRHAGIC SHOCK; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IN VITRO STUDY; IN VIVO STUDY; KIDNEY ISCHEMIA; NEUROPROTECTION; NEWBORN HYPOXIA; NONHUMAN; PNEUMONIA; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TRAUMATIC BRAIN INJURY; DRUG MECHANISM; NEWBORN DISEASE;

ANIMALIA;

ANESTHETICS, INHALATION; ANIMALS; ANIMALS, NEWBORN; BRAIN; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; INFANT, NEWBORN; ISOFLURANE; NEUROPROTECTIVE AGENTS;

EID: 84888266342     PISSN: 10815589     EISSN: 17088267     Source Type: Journal    
DOI: 10.2310/JIM.0b013e3182a07921     Document Type: Conference Paper

References (48)

1. Matchett GA, Allard MW, Martin RD, et al. Neuroprotective effect of volatile anesthetic agents: molecular mechanisms. Neurol Res. 2009;31(2): 128-134.
2. Loepke AW, McCann JC, Kurth CD, et al. The physiologic effects of isoflurane anesthesia in neonatal mice. Anesth Analg. 2006;102(1): 75Y80.
3. Antkowiak B. How do general anaesthetics work Naturwissenschaften. 2001;88(5):201-213.
4. Zuo Z. Are volatile anesthetics neuroprotective or neurotoxic Med Gas Res. 2012;2(1):10.
5. Eger EI 2nd. Isoflurane: A review. Anesthesiology. 1981;55(5):559Y576.
6. Eger EI 2nd. The pharmacology of isoflurane. Br J Anaesth. 1984;56(suppl 1):71SY99S.
7. Chung IS, Kim JA, Kim JA, et al. Reactive oxygen species by isoflurane mediates inhibition of nuclear factor kappaB activation in lipopolysaccharide- induced acute inflammation of the lung. Anesth Analg. 2013;116(2):327Y335.
8. Harr JN, Moore EE, Stringham J, et al. Isoflurane prevents acute lung injury through ADP-mediated platelet inhibition. Surgery. 2012;152(2):270Y276.
9. Kinoshita H, Matsuda N, Iranami H, et al. Isoflurane pretreatment preserves adenosine triphosphate-sensitive K(+) channel function in the human artery exposed to oxidative stress caused by high glucose levels. Anesth Analg. 2012;115(1):54Y61.
10. Kim M, Kim M, Kim N, et al. Isoflurane mediates protection from renal ischemia-reperfusion injury via sphingosine kinase and sphingosine-1- hosphateYdependent pathways. Am J Physiol Renal Physiol. 2007;293(6): F1827YF1835.
11. Lee HT, Ota-Setlik A, Fu Y, et al. Differential protective effects of volatile anesthetics against renal ischemia-reperfusion injury in vivo. Anesthesiology. 2004;101(6):1313Y1324.
12. Lang XE, Wang X, Zhang KR, et al. Isoflurane preconditioning confers cardioprotection by activation of ALDH2. PLoS One. 2013;8(2): e52469.
13. Altay O, Suzuki H, Hasegawa Y, et al. Isoflurane attenuates blood-brain barrier disruption in ipsilateral hemisphere after subarachnoid hemorrhage in mice. Stroke. 2012;43(9):2513Y2516.
14. Li H, Yin J, Li L, et al. Isoflurane postconditioning reduces ischemia-induced nuclear factor-kappaB activation and interleukin 1beta production to provide neuroprotection in rats and mice. Neurobiol Dis. 2013;54:216Y224.
15. Li L, Zuo Z. Isoflurane postconditioning induces neuroprotection via Akt activation and attenuation of increased mitochondrial membrane permeability. Neuroscience. 2011;199:44Y50.
16. Khatibi NH, Ma Q, Rolland W, et al. Isoflurane posttreatment reduces brain injury after an intracerebral hemorrhagic stroke in mice. Anesth Analg. 2011;113(2):343-348.
17. Statler KD, Alexander H, Vagni V, et al. Isoflurane exerts neuroprotective actions at or near the time of severe traumatic brain injury. Brain Res. 2006;1076(1):216Y224.
18. Zhou Y, Lekic T, Fathali N, et al. Isoflurane posttreatment reduces neonatal hypoxic-ischemic brain injury in rats by the sphingosine-1-hosphate/ phosphatidylinositol-3-kinase/Akt pathway. Stroke. 2010;41(7):1521-1527.
19. Vannucci SJ, Hagberg H. Hypoxia-ischemia in the immature brain. J Exp Biol. 2004;207(pt 18):3149Y3154.
20. Sasaoka N, Kawaguchi M, Kawaraguchi Y, et al. Isoflurane exerts a short-term but not a long-term preconditioning effect in neonatal rats exposed to a hypoxic-ischaemic neuronal injury. Acta Anaesthesiol Scand. 2009;53(1):46Y54.
21. Ferriero DM. Neonatal brain injury. N Engl J Med. 2004;351(19): 1985Y1995.
22. Zhao P, Zuo ZY. Isoflurane preconditioning induces neuroprotection that is inducible nitric oxide synthaseYdependent in neonatal rats. Anesthesiology. 2004;101(3):695Y702.
23. Rice JE 3rd, Vannucci RC, Brierley JB, . The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol. 1981;9(2): 131Y141.
24. Vannucci RC, Connor JR, Mauger DT, et al. Rat model of perinatal hypoxic-ischemic brain damage. J Neurosci Res. 1999;55(2):158Y163.
25. Chen H, Burris M, Fajilan A, et al. Prolonged exposure to isoflurane ameliorates infarction severity in the rat pup model of neonatal hypoxia-ischemia. Transl Stroke Res. 2011;2(3):382Y390.
26. Warner DS. Isoflurane neuroprotection: A passing fantasy, again Anesthesiology. 2000;92(5):1223Y1225.
27. Bickler PE, Fahlman CS. The inhaled anesthetic, isoflurane, enhances Ca2+-dependent survival signaling in cortical neurons and modulates MAP kinases, apoptosis proteins and transcription factors during hypoxia. Anesth Analg. 2006;103(2):419Y429, table of contents.
28. Gray JJ, Bickler PE, Fahlman CS, et al. Isoflurane neuroprotection in hypoxic hippocampal slice cultures involves increases in intracellular Ca2+ and mitogen-activated protein kinases. Anesthesiology. 2005;102(3):606Y615.
29. Jamnicki-Abegg M, Weihrauch D, Pagel PS, et al. Isoflurane inhibits cardiac myocyte apoptosis during oxidative and inflammatory stress by activating Akt and enhancing Bcl-2 expression. Anesthesiology. 2005;103(5):1006Y1014.
30. Gwak MS, Cao L, Li L, et al. Isoflurane preconditioning reduces oxygen-glucose deprivation-induced neuronal injury via B-cell lymphoma 2 protein. Environ Toxicol Pharmacol. 2011;31(1):262Y265.
31. Li QF, Zhu YS, Jiang H. Isoflurane preconditioning activates HIF-1alpha, iNOS and Erk1/2 and protects against oxygen-glucose deprivation neuronal injury. Brain Res. 2008;1245:26Y35.
32. Theilmeier G, Schmidt C, Herrmann J, et al. High-density lipoproteins and their constituent, sphingosine-1-hosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor. Circulation. 2006;114(13):1403Y1409.
33. Man K, Ng KT, Lee TK, et al. FTY720 attenuates hepatic ischemia-reperfusion injury in normal and cirrhotic livers. Am J Transplant. 2005;5(1):40Y49.
34. Lochhead KM, Zager RA. Fluorinated anesthetic exposure ''activates'' the renal cortical sphingomyelinase cascade. Kidney Int. 1998;54(2): 373Y381.
35. Pyne S, Pyne N. Sphingosine 1-hosphate signalling and termination at lipid phosphate receptors. Biochim Biophys Acta. 2002;1582(1Y3): 121Y131.
36. Bakar AM, Park SW, Kim M, et al. Isoflurane protects against human endothelial cell apoptosis by inducing sphingosine kinase-1 via ERK MAPK. Int J Mol Sci. 2012;13(1):977Y993.
37. Pitson SM, Moretti PA, Zebol JR, et al. Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation. EMBO J. 2003;22(20): 5491Y5500.
38. Kim M, Park SW, Kim M, et al. Isoflurane activates intestinal sphingosine kinase to protect against renal ischemia-reperfusion Yinduced liver and intestine injury. Anesthesiology. 2011;114(2): 363Y373.
39. Franks NP, Lieb WR. Where do general anaesthetics act Nature. 1978;274(5669):339Y342.
40. Zhao P, Peng L, Li L, et al. Isoflurane preconditioning improves long-term neurologic outcome after hypoxic-ischemic brain injury in neonatal rats. Anesthesiology. 2007;107(6):963Y970.
41. Zuo Z, Wang Y, Huang Y. Isoflurane preconditioning protects human neuroblastoma SH-SY5Y cells against in vitro simulated ischemia-reperfusion through the activation of extracellular signalYregulated kinases pathway. Eur J Pharmacol. 2006;542(1Y3): 84Y91.
42. Zheng S, Zuo Z. Isoflurane preconditioning induces neuroprotection against ischemia via activation of P38 mitogen-activated protein kinases. Mol Pharmacol. 2004;65(5):1172Y1180.
43. Kapinya KJ, Lowl D, Futterer C, et al. Tolerance against ischemic neuronal injury can be induced by volatile anesthetics and is inducible NO synthase dependent. Stroke. 2002;33(7):1889Y1898.
44. Huang PL. Nitric oxide and cerebral ischemic preconditioning. Cell Calcium. 2004;36(3-4):323-329.
45. McAuliffe JJ, Joseph B, Vorhees CV. Isoflurane-delayed preconditioning reduces immediate mortality and improves striatal function in adult mice after neonatal hypoxia-ischemia. Anesth Analg. 2007;104(5): 1066Y1077, tables of contents.
46. Kawaguchi M, Kimbro JR, Drummond JC, et al. Isoflurane delays but does not prevent cerebral infarction in rats subjected to focal ischemia. Anesthesiology. 2000;92(5):1226Y1228.
47. McAuliffe JJ, Loepke AW, Miles L, et al. Desflurane, isoflurane, and sevoflurane provide limited neuroprotection against neonatal hypoxia-ischemia in a delayed preconditioning paradigm. Anesthesiology. 2009;111(3):533Y546.
48. Jevtovic-Todorovic V, Hartman RE, Izumi Y, et al. Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J Neurosci. 2003;23(3):876Y882.